These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34724255)

  • 1. Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.
    Gruen ME; Myers JAE; Tena JS; Becskei C; Cleaver DM; Lascelles BDX
    J Vet Intern Med; 2021 Nov; 35(6):2752-2762. PubMed ID: 34724255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study.
    Gruen ME; Myers JAE; Lascelles BDX
    Front Vet Sci; 2021; 8():610028. PubMed ID: 34124212
    [No Abstract]   [Full Text] [Related]  

  • 3. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study.
    Gruen ME; Thomson AE; Griffith EH; Paradise H; Gearing DP; Lascelles BD
    J Vet Intern Med; 2016 Jul; 30(4):1138-48. PubMed ID: 27334504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration.
    Walters RR; Boucher JF; De Toni F
    Front Vet Sci; 2021; 8():687448. PubMed ID: 34179175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain.
    Gruen ME; Griffith E; Thomson A; Simpson W; Lascelles BD
    J Vet Intern Med; 2014; 28(2):346-50. PubMed ID: 24512390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody.
    Michels GM; Honsberger NA; Walters RR; Kira S Tena J; Cleaver DM
    Vet Anaesth Analg; 2023 Sep; 50(5):446-458. PubMed ID: 37541934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats.
    Gruen ME; Griffith EH; Thomson AE; Simpson W; Lascelles BD
    PLoS One; 2015; 10(7):e0131839. PubMed ID: 26162101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections.
    Storrer A; Mackie JT; Gunew MN; Aslan J
    J Feline Med Surg; 2023 Nov; 25(11):1098612X231198416. PubMed ID: 37975186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease-associated pain.
    Gruen ME; Dorman DC; Lascelles BDX
    Vet Rec; 2017 May; 180(19):473. PubMed ID: 28270539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo.
    Shipley H; Flynn K; Tucker L; Wendt-Hornickle E; Baldo C; Almeida D; Allweiler S; Guedes A
    J Feline Med Surg; 2021 Jun; 23(6):568-574. PubMed ID: 33112193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a nutritional supplement for the alleviation of pain associated with feline degenerative joint disease: a prospective, randomized, stratified, double-blind, placebo-controlled clinical trial.
    Cunningham R; Gruen ME; Thomson A; Lascelles BDX
    J Feline Med Surg; 2022 Oct; 24(10):962-974. PubMed ID: 34719996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis.
    Lascelles BD; Hansen BD; Roe S; DePuy V; Thomson A; Pierce CC; Smith ES; Rowinski E
    J Vet Intern Med; 2007; 21(3):410-6. PubMed ID: 17552444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats.
    Gearing DP; Huebner M; Virtue ER; Knight K; Hansen P; Lascelles BD; Gearing RP; Drew AC
    J Vet Intern Med; 2016 Jul; 30(4):1129-37. PubMed ID: 27306920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats.
    Guedes AGP; Meadows JM; Pypendop BH; Johnson EG; Zaffarano B
    J Am Vet Med Assoc; 2018 Sep; 253(5):579-585. PubMed ID: 30110208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of meloxicam and a glucosamine-chondroitin supplement in management of feline osteoarthritis. A double-blind randomised, placebo-controlled, prospective trial.
    Sul RM; Chase D; Parkin T; Bennett D
    Vet Comp Orthop Traumatol; 2014; 27(1):20-6. PubMed ID: 24146058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
    Corral MJ; Moyaert H; Fernandes T; Escalada M; Kira S Tena J; Walters RR; Stegemann MR
    Vet Anaesth Analg; 2021 Nov; 48(6):943-955. PubMed ID: 34565678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats.
    Benito J; Depuy V; Hardie E; Zamprogno H; Thomson A; Simpson W; Roe S; Hansen B; Lascelles BD
    Vet J; 2013 Jun; 196(3):368-73. PubMed ID: 23369382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain.
    Lascelles BD; Knazovicky D; Case B; Freire M; Innes JF; Drew AC; Gearing DP
    BMC Vet Res; 2015 Apr; 11():101. PubMed ID: 25926287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tramadol for treatment of osteoarthritis in geriatric cats.
    Guedes AGP; Meadows JM; Pypendop BH; Johnson EG
    J Am Vet Med Assoc; 2018 Mar; 252(5):565-571. PubMed ID: 29461159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial.
    Adrian D; King JN; Parrish RS; King SB; C Budsberg S; Gruen ME; Lascelles BDX
    Sci Rep; 2021 Apr; 11(1):7721. PubMed ID: 33833276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.